SCHEMBL848086

SCHEMBL848086

O=C(CCc1ccc(C(F)(F)F)cc1)Nc1cnc2ccccc2c1

nearest known ligand 0.62

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MCHR1 Q99705 13/20 0.62
MEN1 O00255 1/20 0.61
KMT2A Q03164 1/20 0.61
HDAC3 O15379 3/20 0.59
HDAC4 P56524 3/20 0.59
HDAC1 Q13547 3/20 0.59
HDAC7 Q8WUI4 3/20 0.59
HDAC2 Q92769 3/20 0.59
HDAC10 Q969S8 3/20 0.59
HDAC11 Q96DB2 3/20 0.59
HDAC8 Q9BY41 3/20 0.59
HDAC6 Q9UBN7 3/20 0.59
HDAC9 Q9UKV0 3/20 0.59
HDAC5 Q9UQL6 3/20 0.59
TRPV1 Q8NER1 2/20 0.57
CNR1 P21554 1/20 0.57
CNR2 P34972 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL846968 0.89 TRPV1 (0.67) MEN1KMT2AHDAC3HDAC4HDAC1
SCHEMBL13991492 0.87 HDAC1 (0.72) MEN1KMT2AHDAC3HDAC4HDAC1
SCHEMBL846178 0.86 MEN1 (0.60) MEN1KMT2AHDAC3HDAC4HDAC1
SCHEMBL13991505 0.85 MEN1 (0.67) MEN1KMT2AHDAC3HDAC4HDAC1
SCHEMBL846038 0.84 MEN1 (0.58) MCHR1MEN1KMT2AHDAC3HDAC4
SCHEMBL1577038 0.83 TRPV1 (0.76) MEN1KMT2AHDAC3HDAC4HDAC1
SCHEMBL846613 0.82 TRPV1 (0.62) MEN1KMT2AHDAC3HDAC4HDAC1
SCHEMBL5776350 0.82 MAPT (0.51) MCHR1MEN1KMT2AHDAC3HDAC4
SCHEMBL4949897 0.82 TRPV1 (0.53) MCHR1MEN1KMT2AHDAC3HDAC4
SCHEMBL29432900 0.82 CNR1 (0.57) HDAC6TRPV1CNR1CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1603883-B1 QUINOLINE-DERIVED AMIDE MODULATORS OF VANILLOID VR1 RECEPTOR JANSSEN PHARMACEUTICA NV (BE) 2012-03-28 EP disclosed
EP-2308848-A1 Quinoline-derived amide modulators of vanilloid VR1 receptor Janssen Pharmaceutica NV (BE) 2011-04-13 EP disclosed